T. Rowe Price Health Sciences Fund (PRHSX)

Access innovative companies in a dynamic industry.

Call 866-349-5897 to speak to an investment specialist about the
Health Sciences Fund.

Ticker Symbol:
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 03/31/2019
Volatility and Other Measures
as of 03/31/2019
Beta 1.34
Active Share 90.83
Standard Deviation 15.89
Price/Earnings Ratio (Domestic) 24.3
Earnings Growth Rate (Domestic) 11.7
Turnover Rate 8.4
Median Market
$44,871.4 Million
Sector Diversification
as of 03/31/2019
% of Total Net Assets
Biotechnology 32.4%
Products & Devices 21.4%
Services 20.5%
Pharmaceuticals 15.5%
Life Sciences 10.0%
Miscellaneous 0.1%
10 Largest Holdings
Represents 36.47 % of Total Net Assets
View Holdings as of:
Becton, Dickinson & Company
Eli Lilly
Intuitive Surgical
SAGE Therapeutics
Thermo Fisher Scientific
UnitedHealth Group
Vertex Pharmaceuticals
As of 03/31/2019 the Health Sciences Fund had a total of 191 holdings.
See Glossary for additional details on all data elements.